                         SEQUENCE LISTING

<110>  OREGON HEALTH & SCIENCE UNIVERSITY
 
<120>  Y BOX BINDING PROTEIN 1 INHIBITORS

<130>  Tech 2964-3

<150>  63/256,609
<151>  2021-10-17

<150>  63/121,674
<151>  2020-12-04

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  pLV[shRNA]-EFGP:T2A:Puro-U6>hYBX1[shRNA#1]

<400>  1
cctgttaata aaggtcttaa a                                                 21


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  pLV[shRNA]-EFGP:T2A:Puro-U6>hYBX1[shRNA#2]

<400>  2
ccagttcaag gcagtaaata t                                                 21


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  pLV[shRNA]-EGFP:T2A:Puro-U6>Scramble[shRNA#1]

<400>  3
cctaaggtta agtcgccctc g                                                 21


<210>  4
<211>  348
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Recombinant human YB-1 protein (His Tag) (Novus Biological Cat. 
       No. NBP2-30101)

<400>  4

Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro 
1               5                   10                  15      


Arg Gly Ser His Met Gly Ser Met Ser Ser Glu Ala Glu Thr Gln Gln 
            20                  25                  30          


Pro Pro Ala Ala Pro Pro Ala Ala Pro Ala Ser Leu Ser Ala Ala Asp 
        35                  40                  45              


Thr Lys Pro Gly Thr Thr Gly Ser Gly Ala Gly Ser Gly Gly Pro Gly 
    50                  55                  60                  


Gly Leu Glu Thr Ser Ala Ala Pro Ala Gly Gly Asp Lys Lys Val Ile 
65                  70                  75                  80  


Ala Thr Lys Val Leu Gly Thr Val Lys Trp Phe Asn Val Arg Asn Gly 
                85                  90                  95      


Tyr Gly Phe Ile Asn Arg Asn Asp Thr Lys Glu Asp Val Phe Val His 
            100                 105                 110         


Gln Thr Ala Ile Lys Lys Asn Asn Pro Arg Lys Tyr Leu Arg Ser Val 
        115                 120                 125             


Gly Asp Gly Glu Thr Val Glu Phe Asp Val Val Glu Gly Glu Lys Gly 
    130                 135                 140                 


Ala Glu Ala Ala Asn Val Thr Gly Pro Gly Gly Val Pro Val Gln Gly 
145                 150                 155                 160 


Ser Lys Tyr Ala Ala Asp Arg Asn His Tyr Arg Arg Tyr Pro Arg Arg 
                165                 170                 175     


Arg Gly Pro Pro Arg Asn Tyr Gln Gln Asn Tyr Gln Asn Ser Glu Ser 
            180                 185                 190         


Gly Glu Lys Asn Glu Gly Ser Glu Ser Ala Pro Glu Gly Gln Ala Gln 
        195                 200                 205             


Gln Arg Arg Pro Tyr Arg Arg Arg Phe Pro Pro Tyr Tyr Met Arg Arg 
    210                 215                 220                 


Pro Tyr Gly Arg Arg Pro Gln Tyr Ser Asn Pro Pro Val Gln Gly Glu 
225                 230                 235                 240 


Val Met Glu Gly Ala Asp Asn Gln Gly Ala Gly Glu Gln Gly Arg Pro 
                245                 250                 255     


Val Arg Gln Asn Met Tyr Arg Gly Tyr Arg Pro Arg Phe Arg Arg Gly 
            260                 265                 270         


Pro Pro Arg Gln Arg Gln Pro Arg Glu Asp Gly Asn Glu Glu Asp Lys 
        275                 280                 285             


Glu Asn Gln Gly Asp Glu Thr Gln Gly Gln Gln Pro Pro Gln Arg Arg 
    290                 295                 300                 


Tyr Arg Arg Asn Phe Asn Tyr Arg Arg Arg Arg Pro Glu Asn Pro Lys 
305                 310                 315                 320 


Pro Gln Asp Gly Lys Glu Thr Lys Ala Ala Asp Pro Pro Ala Glu Asn 
                325                 330                 335     


Ser Ser Ala Pro Glu Ala Glu Gln Gly Gly Ala Glu 
            340                 345             


